共 50 条
The Swedish version of the Motivation and Pleasure Scale self-report (MAP-SR): psychometric properties in patients with schizophrenia or depression
被引:1
|作者:
Cernvall, Martin
[1
,2
]
Bengtsson, Johan
[1
]
Boden, Robert
[1
]
机构:
[1] Uppsala Univ, Dept Med Sci, Psychiat, Uppsala, Sweden
[2] Uppsala Univ, Dept Med Sci, Psychiat, Ing 10, S-75185 Uppsala, Sweden
基金:
瑞典研究理事会;
关键词:
Assessment;
depression;
negative symptoms;
schizophrenia;
CLINICAL-ASSESSMENT INTERVIEW;
NEGATIVE SYMPTOMS;
RATING-SCALE;
GERMAN VERSION;
VALIDATION;
ANHEDONIA;
VALIDITY;
RELIABILITY;
CONSENSUS;
D O I:
10.1080/08039488.2024.2324060
中图分类号:
R749 [精神病学];
学科分类号:
100205 ;
摘要:
Purpose: Negative symptoms are commonly regarded as a symptom dimension belonging to schizophrenia spectrum disorders but are also present in depression. The recently developed Clinical Assessment Interview for Negative Symptoms (CAINS) has shown to be reliable and valid. A corresponding self-report questionnaire has also been developed, named the Motivation and Pleasure Scale - Self Report (MAP-SR). The purpose was to evaluate the psychometric properties of the Swedish version of the MAP-SR in patients with either schizophrenia or depression. Materials and Methods: The MAP-SR was translated to Swedish. Participants were 33 patients with schizophrenia spectrum disorders and 52 patients with a depressive disorder and they completed the MAP-SR, the CAINS and other measures assessing adjacent psychopathology, functioning and cognition. Results: The internal consistency for the MAP-SR was adequate in both groups (schizophrenia spectrum alpha = .93, depressive disorder alpha = .82). Furthermore, the MAP-SR had a large correlation to the motivation and pleasure subscale of the CAINS in patients with schizophrenia disorders (r = -0.75, p < .001), however among patients with depression this correlation was medium-to-large (r = -0.48, p < 0.001). Conclusions: Findings suggest that the Swedish version of the MAP-SR shows promise as a useful measure of motivation and pleasure, especially in patients with schizophrenia spectrum disorders. Furthermore, results also suggest that the MAP-SR does not assess negative symptoms specifically, but that there is an overlap between depressive and negative symptoms.
引用
收藏
页码:339 / 346
页数:8
相关论文